Impact of adalimumab in patients with active non-infectious intermediate, posterior, and panuveitis in real-life clinical practice: HOPE study

Conclusion
These results demonstrated adalimumab effectiveness in improving quality of life while reducing economic burden of active NIIPPU.

Source: British Journal of Ophthalmology - November 22, 2023 Category: Opthalmology Authors: Pleyer, U., Al-Mutairi, S., Murphy, C. C., Hamam, R., Hammad, S., Nagy, O., Szepessy, Z., Guex-Crosier, Y., Julian, K., Habot-Wilner, Z., Androudi, S. Tags: Open access Original articles - Clinical science Source Type: research